Abstract:Background: The intravoxel incoherent motion (IVIM) method of magnetic resonance imaging (MRI) analysis can provide information regarding many physiological and pathological processes. This study aimed to investigate whether IVIM-derived parameters and the apparent diffusion coefficient (ADC) can act as imaging biomarkers for predicting non-small cell lung cancer (NSCLC) response to anti-tumor therapy and compare their performances. Methods: This prospective study included 45 patients with NSCLC treated with chemotherapy (29 men and 16 women, mean age 57.9 +/- 9.7 years). Diffusion-weighted imaging was performed with 13 b-values before and 2-4 weeks after treatment. The IVIM parameter pseudo-diffusion coefficient (D*), perfusion fraction (f), diffusion coefficient (D), and ADC from a mono-exponential model were obtained. Responses 2 months after chemotherapy were assessed. The diagnostic performance was evaluated, and optimal cut-off values were determined by receiver operating characteristic (ROC) curve analysis, and the differences of progression-free survival (PFS) in groups of responders and non-responders were tested by Cox regression and Kaplan-Meier survival analyses. Results: Of 45 patients, 30 (66.7%) were categorized as responders, and 15 as non-responders. Differences in the diffusion coefficient D and ADC between responders and non-responders were statistically significant (all P<0.05). Conversely, differences in f and D* between responders and non-responders were both not statistically significance (all P>0.05). The ROC analyses showed the change in D value (Delta D) was the best predictor of early response to anti-tumor therapy [area under the ROC curve (AUC), 0.764]. The Cox-regression model showed that all ADC and D parameters were independent predictors of PFS, with a range of reduction in risk from 56.2% to 82.7%, and Delta D criteria responders had the highest reduction (82.7%). Conclusions: ADC and D derived from IVIM are potentially useful for the prediction of NSCLC treatment response to anti-tumor therapy. Although Delta D is best at predicting response to treatment, Delta ADC measurement may simplify manual efforts and reduce the workload.

Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer

Apparent Diffusion Coefficient Histogram Shape Analysis for Monitoring Early Response in Patients with Advanced Cervical Cancers Undergoing Concurrent Chemo-Radiotherapy

The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients

Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.

Using Apparent Diffusion Coefficient (ADC) of Endometrial Cancer MRI to Determine P53 Molecular Subtypes

Whole Lesion Histogram Analysis of Apparent Diffusion Coefficients on MRI Predicts Disease-Free Survival in Locally Advanced Squamous Cell Cervical Cancer after Radical Chemo-Radiotherapy

The Ability of ADC Measurements in the Assessment of Patients with Stage I Endometrial Carcinoma Based on Three Risk Categories

Early Evaluation of Cancer Response by a New Functional Biomarker: Apparent Diffusion Coefficient.

Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy

Utility of the relative apparent diffusion coefficient for preoperative assessment of low risk endometrial carcinoma.

The Utility of Measuring the Apparent Diffusion Coefficient for Peritumoral Zone in Assessing Infiltration Depth of Endometrial Cancer.

Clinical Application of Diffusion-Weighted Magnetic Resonance Imaging in Uterine Cervical Cancer

MRI-based Radiomics and ADC Values Are Related to Recurrence of Endometrial Carcinoma：A Preliminary Analysis

The value of apparent diffusion coefficient in the assessment of cervical cancer

Apparent Diffusion Coefficient (ADC) Value: A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer

Estimating pathological prognostic factors in epithelial ovarian cancers using apparent diffusion coefficients of functional tumor volume

Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT.

Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer

Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness.

Apparent Diffusion Coefficient Histogram Analysis for Assessing Tumor Staging and Detection of Lymph Node Metastasis in Epithelial Ovarian Cancer: Correlation with P53 and Ki-67 Expression

Use of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) to Predict Early Response to Anti-Tumor Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): a Comparison of Intravoxel Incoherent Motion-Derived Parameters and Apparent Diffusion Coefficient